SLU-PP-332 is a synthetic small-molecule ERR agonist offered by Molecule Frontier for advanced laboratory research. As a pan-agonist of the estrogen-related receptor family — ERRα, ERRβ, and ERRγ — SLU-PP-332 is used in preclinical studies exploring mitochondrial function, oxidative metabolism, cellular respiration, and exercise-mimetic signaling pathways.

Published research has evaluated SLU-PP-332 in skeletal muscle and metabolic models, where ERR activation was associated with changes in mitochondrial activity, fatty-acid oxidation, oxidative muscle-fiber markers, and endurance-related gene programs. This makes SLU-PP-332 a valuable research tool for scientists studying nuclear receptor biology, mitochondrial bioenergetics, metabolic flexibility, and the transcriptional programs that overlap with aerobic exercise adaptation.

For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.